The Worldwide Biosimilars Industry is Expected to Reach $47.4 Billion by 2027: Patent Expiration of Well-Known Biologics Drives Growth
10 févr. 2023 11h03 HE
|
Research and Markets
Dublin, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Biosimilars Market Size, Trends and Growth Opportunity, By Product, By Indication, By Region and Forecast to 2027." report has been added to ...
Biosimilar Contract Manufacturing Global Market Report 2022: Favorable Policies Encouraging Use of Biosimilars Present Opportunities
12 janv. 2023 07h23 HE
|
Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "Biosimilar Contract Manufacturing Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.The...
Insights on the Oncology Biosimilars Global Market to 2027: Rising Number of Geriatric Population and Environmental Degradation Drives Growth
03 janv. 2023 05h28 HE
|
Research and Markets
Dublin, Jan. 03, 2023 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Oncology Biosimilars Global Market Report 2022: Increasing Approvals in North America to Set the Stage for Swift Growth
09 déc. 2022 05h58 HE
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Biosimilar Therapeutic Peptides Global Market Report 2022: Research Collaborations Present Lucrative Opportunities for Growth
24 nov. 2022 06h53 HE
|
Research and Markets
Dublin, Nov. 24, 2022 (GLOBE NEWSWIRE) -- The "Biosimilar Therapeutic Peptides Global Market Report 2022: By Route, By Application, By Type" report has been added to ResearchAndMarkets.com's...
Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2022: Featuring Zydus Cadila, Abbvie, Samsung Bioepis & More
18 nov. 2022 08h08 HE
|
Research and Markets
Dublin, Nov. 18, 2022 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2022: By Product, By Application, By Distribution" report has been added to ...
Biosimilar Growth Hormones Global Market Report 2022: Recombinant DNA Technology Presents Lucrative Opportunities
10 nov. 2022 07h43 HE
|
Research and Markets
Dublin, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The "Biosimilar Growth Hormones Global Market Report 2022: By Route, By Application, By Distribution" report has been added to ResearchAndMarkets.com's...
Global Biosimilars Market Report 2022: Featuring Pfizer, Samsung Bioepis, Novartis, Mylan, Eli Lilly, Merck & More
10 nov. 2022 05h13 HE
|
Research and Markets
Dublin, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The "Global Biosimilars Market, By Indication Type, By Product & By Region- Forecast and Analysis 2022-2028" report has been added to ...
Biosimilar Lymphocyte Modulator Global Market Report 2022: Growing Popularity of Immunotherapy for Cancer Treatment Driving Sector
08 nov. 2022 04h53 HE
|
Research and Markets
Dublin, Nov. 08, 2022 (GLOBE NEWSWIRE) -- The "Biosimilar Lymphocyte Modulator Global Market Report 2022: By Drug, By Disease" report has been added to ResearchAndMarkets.com's offering. The...
Biosimilar Interleukins Global Market Report 2022: Featuring MabPharm, Gedeon Richter, Bio-Thera Solutions, Sorrento Therapeutics & Sunshine Guojian Pharmaceutical
02 nov. 2022 05h58 HE
|
Research and Markets
Dublin, Nov. 02, 2022 (GLOBE NEWSWIRE) -- The "Biosimilar Interleukins Global Market Report 2022: By Type, By Application, By Distribution" report has been added to ResearchAndMarkets.com's...